Walleye Capital’s MacroGenics MGNX Stock Holding History

Walleye Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1K	Sell	2,400 -73,400	-97%	-$278K	﹤0.01%	4481
2026 Q1	$219K	Buy	+75,800	New	+$162K	﹤0.01%	3284

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Walleye Capital's MGNX Position: Q2 2026 in Review

Walleye Capital increased its MacroGenics (MGNX) stake by 22% in Q2 2026, buying an estimated $276K and bringing the position to 408,150 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #1565.

Walleye Capital first reported a position in MGNX in Q1 2022 and has held it in 13 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Walleye Capital held 408,150 shares of MacroGenics worth $1.89M as of Q2 2026.
Walleye Capital bought 72,885 MacroGenics shares in Q2 2026, an estimated $276K.
MacroGenics made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1565 holding.
Walleye Capital first reported a position in MacroGenics in Q1 2022 and has held it in 13 quarters since.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.